卡替洛尔滴眼液局部外用治疗婴儿浅表血管瘤的临床观察

Abstract
Figure/Table
References (17)
Related Citation (15)

Download: PDF (0 KB) HTML (32 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To study the clinical effect of topical application of Carteolol Eye Drops in the treatment of infantile superficial hemangioma.Methods A total of 76 children with superficial hemangioma who were admitted to the Department of Dermatology, Maternal and Child Health Hospital of Ganzhou City from January 2018 to December 2019 were selected as the research subjects.The children were divided into 2 groups by the random number table method,38 cases in each group.The control group was treated with topical application of 5% Imiquimod Cream, and the observation group was treated with topical Carteolol Eye Drops.The treatment effect and the adverse reactions were compared between the two groups.Results After 6 months of treatment, the total effective rate of the observation group was higher than that of the control group, and the difference was statistically significant （P＜0.05）.There was no significant difference in the total incidence of adverse reactions between the two groups （P＞0.05）.Conclusion Carteolol Eye Drops for local topical treatment of infant superficial hemangioma have a definite clinical effect, can improve the cure rate, and have a low incidence of adverse reactions, and have high drug safety.

Key words： Carteolol Eye Drops Infant Superficial hemangioma Adverse reaction

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	QIU Jian-wen
	SHU Jian
	WU Long-mao
	LI Jian
	LIU Yan-qing

Cite this article:

QIU Jian-wen,SHU Jian,WU Long-mao, et al. Clinical observation of topical application of Carteolol Eye Drops in treating infantile superficial hemangioma[J]. 中国当代医药, 2021, 28(29): 64-66转70.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2021/V28/I29/64

[1]	孙羽.婴幼儿血管瘤治疗方法的研究探讨[D].武汉：华中科技大学，2011.
[2]	叶雯霞，金宛宛，全和和，等.595 nm 染料激光联合外用0.5%马来酸噻吗洛尔溶液治疗浅表型婴儿血管瘤的疗效评价[J].中华皮肤科杂志，2018，51（12）：888-892.
[3]	Waner M，Suen JY.Management of congenital vascular lesions of the head and neck[J].Oncology，1995，9（10）：989.
[4]	Achauer BM ，Chang CJ，Vander VM.Management of Hemangioma of Infancy：Review of 245 Patients[J].Plast Reconstr Surg，1997，99（5）：1301-1308.
[5]	苗晓腾，宋维铭.婴幼儿血管瘤发生发展与消退：干细胞、内皮细胞及细胞因子的参与及作用[J].中国组织工程研究，2014，18（15）：2434-2441.
[6]	蔡湘娜，林晓斌，李吉林，等.β3 肾上腺素受体及血管内皮细胞生长因子在婴幼儿血管瘤组织中的表达[J].中国临床研究，2015，28（11）：1506-1508.
[7]	Zoltán D，Simona G，Ioan J，et al.Arteriovenous synovial hemangioma of the popliteal fossa diagnosed in an adolescent with history of unilateral congenital clubfoot：case report and a single-institution retrospective review[J].Rom J Morphol Embryol.2015，56（2）：549-552.
[8]	Yeong JY，Yun HG，Sohyoung Y，et al.A prospective study to assess the efficacy and safety of oral propranolol as firstline treatment for infantile superficial hemangioma[J].Korean J Pediatr，2015，58（12）：484-490.
[9]	李铭，郭志辉，谢义德，等.口服普萘洛尔对婴幼儿血管瘤相关生长因子及凋亡因子表达水平的影响[J].解放军医学杂志，2015，40（2）：121-127.
[10]	李丽琴，郭竹秀，吴俭，等.口服普萘洛尔治疗婴幼儿增生期血管瘤疗效分析及血清血管内皮生长因子的变化[J].临床皮肤科杂志，2014，43（11）：682-684.
[11]	Roland HS，Nor AM，Jennifer LB，et al.The post-prandial rise in plasma cortisol in men is mediated by macronutrient-specific stimulation of adrenal and extra-adrenal cortisol production.[J].J Clin Endocrinol Metab，2014，99（1）：160-168.
[12]	林晓，钱秋芳，黄迎，等.噻吗洛尔和卡替洛尔外用治疗婴幼儿血管瘤疗效观察[J].国际皮肤性病学杂志，2016，42（6）：441-443.
[13]	雷红召，孟小分，董长宪，等.颈外动脉置管药物灌注治疗婴幼儿口腔颌面部重症血管瘤的疗效[J].中华实用儿科临床杂志，2016，31（18）：1432-1434.
[15]	李云玲，郑惠文.卡替洛尔联合糠酸莫米松治疗婴儿早期浅表生长期血管瘤的临床效果观察[J].浙江医学，2020，v.42（18）：105-107.
[16]	魏景健，司亚萌，张爱侠，等.马来酸噻吗洛尔滴眼液治疗婴幼儿增殖期浅表血管瘤的疗效[J].中华医学美学美容杂志，2019，25（3）：248-249.
[14]	Camila D，Guillermo P，María JZ，et al.Symplastic hemangioma developing over an infantile hemangioma during propranolol treatment[J].Pediatr Dermatol，2019，36（6）：961-962.
[17]	常锦萍.噻吗洛尔和卡替洛尔分别与普萘洛尔联合应用治疗婴幼儿血管瘤的疗效观察[J].中国执业药师，2019，16（5）：117-121.